ftInvstr
ASTRAZEN · Healthcare ₹6529.0 +0.76% Mkt Cap ₹16209 Cr

ASTRAZEN

Healthcare Drug Manufacturers - Specialty & Generic
₹6529.0
+0.76% today · 30d +11.23%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for ASTRAZEN. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-09-30
REVENUE
₹729 Cr
+30.41% YoY
NET PROFIT
₹62 Cr
+14.96% YoY
OPM
14.87%
+0.48pp YoY
EPS
₹24.93
PE 91.53
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-0.1% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
ASTRAZEN91.53—
SUNPHARMA37.7921.44
DIVISLAB93.121.56
ZYDUSLIFE28.424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
47
SCORE / 100
Overall
6-axis composite of the sections below.
Performance UNDERPERFORMER 5
Valuation STRETCHED 20
Growth STRONG 80
Profitability DECENT 55
Technicals WEAK 43
Risk LOW 80
Key Stats
TTM PE
91.53
P/B
18.51
52W HIGH
₹9849.5
OFF HIGH
-33.71%
DIV YIELD
0.55%
MKT CAP
₹16209 Cr
◉ Active Signals
MACDBullish69.6443
RSI(14)Bullish63.3
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold ASTRAZEN and at what entry.

Sign up freeSign in